Caffeine Completed Phase 4 Trials for Type 2 Diabetes Mellitus Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science4
clinicaltrials.gov IdentifierTitleDrugs
NCT02291666Evaluation of CYP450 Activities in Diabetic Patients vs. Non-diabetic Subjects